MAGAN KAUHI: Open Payments
NPI 1710412630 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,744 in 109 payments from 15 companies in 2025. Trend: 2023 $1,435 · 2024 $1,653 · 2025 $1,744
Food & beverage: $1,744
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 35 | $449 |
| PFIZER INC. | 12 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $206 |
| Philips North America LLC | 5 | $140 |
| Alnylam Pharmaceuticals Inc. | 5 | $121 |
| Novo Nordisk Inc | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $92 |
| Merck Sharp & Dohme LLC | 5 | $83 |
| Actelion Pharmaceuticals US, Inc. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
Products named: LEQVIO, JARDIANCE, ELIQUIS, AMVUTTRA, Wegovy, CAMZYOS, MCOT, Ambulatory Monitoring & Diagnostics Undivided.
Industry payments across TN — which companies pay providers there.
